Vimarsana
Biggest News Aggregation in the World

Page 9 - Zai Lab News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Zai Lab. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Zai Lab Today - Breaking & Trending Today

Zai Lab Limited (NASDAQ:ZLAB) CEO Sells $93,460.05 in Stock - Vimarsana News

Zai Lab Limited (NASDAQ:ZLAB) CEO Sells $93,460.05 in Stock

Zai Lab Limited (NASDAQ:ZLAB – Get Free Report) CEO Ying Du sold 5,787 shares of the company’s stock in a transaction on Tuesday, April 2nd. The stock was sold at an average price of $16.15, for a total transaction of $93,460.05. Following the completion of the sale, the chief executive officer now owns 1,107,972 shares […]

Zai Lab Limited (NASDAQ:ZLAB) Insider Joshua L. Smiley Sells 1,988 Shares of Stock - Vimarsana News

Zai Lab Limited (NASDAQ:ZLAB) Insider Joshua L. Smiley Sells 1,988 Shares of Stock

Zai Lab Limited (NASDAQ:ZLAB – Get Free Report) insider Joshua L. Smiley sold 1,988 shares of the company’s stock in a transaction that occurred on Thursday, April 4th. The shares were sold at an average price of $15.67, for a total value of $31,151.96. Following the completion of the transaction, the insider now directly owns […]

Joshua L. Smiley Sells 1,988 Shares of Zai Lab Limited (NASDAQ:ZLAB) Stock - Vimarsana News

Joshua L. Smiley Sells 1,988 Shares of Zai Lab Limited (NASDAQ:ZLAB) Stock

Zai Lab Limited (NASDAQ:ZLAB – Get Free Report) insider Joshua L. Smiley sold 1,988 shares of the firm’s stock in a transaction dated Thursday, April 4th. The stock was sold at an average price of $15.67, for a total transaction of $31,151.96. Following the completion of the sale, the insider now owns 28,684 shares of […]

NHS AI Breakthrough: Tiny Cancer Detection Surpasses Doctor - Vimarsana News

NHS AI Breakthrough: Tiny Cancer Detection Surpasses Doctor

With NHS's AI, tiny cancers no longer escape detection, promising a significant leap in early diagnosis and improved patient outcomes.

China pharma must swallow that jagged little pill called R&D as government slashes profit margins of generic drugs - Vimarsana News

China pharma must swallow that jagged little pill called R&D as government slashes profit margins of generic drugs

Beijing wants cheaper, better drugs. That’s pressuring drug makers to innovate as generics become more competitive.

Source: scmp.com